Brain Scientific Inc.
BRSF
$0.75
-$0.35-31.82%
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Revenue | -97.97% | 115.09% | 400.00% | 10,540.00% | 192.53% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -97.97% | 115.09% | 400.00% | 10,540.00% | 192.53% |
| Cost of Revenue | -93.42% | 0.00% | 1,125.81% | 17,683.33% | 172.01% |
| Gross Profit | -108.49% | 572.73% | -89.13% | 5,777.78% | 364.14% |
| SG&A Expenses | -71.87% | 135.50% | 102.50% | 185.17% | 243.80% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -72.08% | 131.87% | 107.90% | 189.76% | 340.04% |
| Operating Income | 70.82% | -131.92% | -105.79% | -167.78% | -243.57% |
| Income Before Tax | 41.48% | -146.38% | -124.30% | -230.26% | -707.22% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 41.48% | -146.38% | -124.30% | -230.26% | -707.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 41.48% | -146.38% | -124.30% | -230.26% | -707.22% |
| EBIT | 70.82% | -131.92% | -105.79% | -167.78% | -243.57% |
| EBITDA | 74.13% | -121.55% | -88.06% | -141.26% | -233.96% |
| EPS Basic | 80.76% | 31.00% | -8.35% | -92.86% | -951.00% |
| Normalized Basic EPS | 85.00% | 31.00% | -8.35% | -64.59% | -1,149.96% |
| EPS Diluted | 80.76% | 31.00% | -8.35% | -92.86% | -977.51% |
| Normalized Diluted EPS | 85.00% | 31.00% | -8.35% | -64.59% | -1,149.96% |
| Average Basic Shares Outstanding | 204.22% | 257.04% | 107.00% | 71.26% | -28.64% |
| Average Diluted Shares Outstanding | 204.22% | 257.04% | 107.00% | 71.26% | -28.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
